Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

New Peer-Reviewed Study Finds Illegal Online Pharmacies Use Twitter to Sell Percocet®, Fentanyl, Vicodin®, Oxycontin® and Other Controlled Substances to U.S. Consumers
  • USA - English


News provided by

ECI Communications

Oct 25, 2017, 12:05 ET

Share this article

Share toX

Share this article

Share toX

Timothy K. Mackey, PhD, MAS, Associate Professor of Anesthesiology and Global Public Health at UC San Diego School of Medicine
Timothy K. Mackey, PhD, MAS, Associate Professor of Anesthesiology and Global Public Health at UC San Diego School of Medicine

SAN DIEGO, CA (PRWEB) October 25, 2017 -- Results from a new peer-reviewed study to be published in the November issue of American Journal of Public Health (AJPH) found illegal online pharmacies are using Twitter to market and sell hydrocodone, fentanyl and oxycodone and other highly addictive and often deadly controlled substances to U.S. consumers, in direct violation of U.S. federal law.

The sale of fentanyl, hydrocodone, oxycodone and other controlled substances via the Internet is not only in direct violation of the 2008 Ryan Haight Online Pharmacy Consumer Protection Act, but also exacerbates the opioid epidemic and puts Americans at risk of receiving counterfeit medicines.

Post this

“Machine Learning to Detect Prescription Opioid Abuse Promotion and Access via Twitter,” conducted in-part through a grant from the Alliance for Safe Online Pharmacies (ASOP Global), was co-authored by Timothy K. Mackey, PhD, MAS, Associate Professor of Anesthesiology and Global Public Health at UC San Diego School of Medicine and Director of Healthcare Research and Policy at UC San Diego Extension, Janani Kalyanam, PhD, MS, Takeo Katsuki, PhD, and Gert Lanckriet, PhD.

Dr. Mackey explained that the authors used innovative methodology involving “big data”, cloud computing and machine learning to accurately identify Tweets marketing the illegal online sale of controlled substances.

“Our methodology resulted in the analysis of 619,937 Tweets containing the keywords for addictive and highly-abused prescription drugs including codeine, Percocet®, fentanyl, Vicodin®, Oxycontin®, oxycodone, and hydrocodone over a five-month period from June to November 2015,” Dr. Mackey said.

“Of these, 1,778 Tweets were identified as marketing the sale of controlled substances online and 90% had imbedded hyperlinks, but only 46 were ‘live’ at the time of our evaluation.

Seven distinct URLs were identified as linked to websites marketing or illegally selling controlled substances online and included registry information from several countries including Pakistan; in 2016, two Pakistani nationals were sentenced by the U.S. Department of Justice for illegally shipping $2 million of pharmaceuticals worldwide, including $78 million worth of drugs to the U.S., through illegal pharmacy websites.

INTERACTIVE MAP OF STUDY RESULTS

“As evidenced by our findings, extremely questionable vendors are illegally advertising highly addictive controlled substances and selling them directly to consumers via Twitter using different strategies, including through ‘no prescription required’ websites and online classified ads, without the necessary oversight of a clinician, regulatory agency, or state public health or law enforcement agency,” Dr. Mackey explained.

“At the time of the completion of our study, the rogue websites we identified remained active online, continuing to place the public at risk; in fact, one identified online pharmacy is still actively selling controlled substances online, almost two years after our data collection,” he added.

THE U.S. OPIOID EPIDEMIC AND ILLEGAL ONLINE PHARMACIES
The Ryan Haight Online Pharmacy Consumer Protection Act (RHA), named for a San Diego teen who died after purchasing prescription opioids online, was designed to respond to the growing use of the Internet to illegally market and sell controlled substances directly to consumers. The law states that “no controlled substance may be delivered, distributed, or dispensed by means of the Internet without a valid prescription.”

The U.S. Centers for Disease Control and Prevention (CDC) has declared a national opioid medication overdose epidemic, reporting that deaths attributable to controlled medications have more than quadrupled since 1999.

“Policies aimed at curbing prescription opioid abuse have focused on establishing guidelines to prevent inappropriate prescribing, developing abuse deterrents, regulating ‘pill mills’, and preventing drug diversion, such as through state prescription drug monitoring programs,” Dr. Mackey said.

“However, the role of the Internet and its continued promotion of prescription opioid abuse remains inadequately addressed despite the passage of RHA in 2008," Mackey explained.

“Specifically, Internet technology is now ubiquitous – 84% of American adults use the Internet and 65% use a social networking site – fueling the growth of dubious pharmacy websites, estimated in the tens of thousands globally.”

Earlier this month, Operation Pangea X, which involved INTERPOL, police, and customs and health regulatory authorities from 123 countries, including the U.S., Canada and the EU, resulted in the removal of 3,584 illegal online pharmacy websites, and suspension of more than 3,000 illegal online advertisements for illicit drugs.

“Despite recent law enforcement efforts, there are still more than 30,000 illegal online pharmacies at any given time, and thousands of these websites advertise opioids without a prescription,” said ASOP Global Executive Director, Libby Baney.

“The results of Dr. Mackey’s study further evidence the need for continued vigilance against illegal online pharmacies that peddle controlled substances, counterfeit medicines, and other illegal products to patients around the world.”

ABOUT THE ALLIANCE FOR SAFE ONLINE PHARMACIES
Headquartered in Washington, D.C., the Alliance for Safe Online Pharmacies (ASOP Global) is an international non-profit organization dedicated to combatting illegal online pharmacies and counterfeit medicines through advocacy, research and education to make the Internet safe for consumers worldwide.

Caren Kagan Evans, ECI Communications, +1 (301) 467-6337, [email protected]

Modal title

ASOP Global Executive Director Libby Baney
ASOP Global Executive Director Libby Baney
Alliance for Safe Online Pharmacies
Alliance for Safe Online Pharmacies
www.BuySafeRx.pharmacy
www.BuySafeRx.pharmacy
ASOP Global Executive Director Libby Baney Alliance for Safe Online Pharmacies www.BuySafeRx.pharmacy

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.